Virendra Singh

Virendra Singh is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as Deputy General Manager at MedTherapy Biotech since May 2024, where responsibilities include establishing and managing the Department of MSAT and GMP Operations for LVV and Cell Therapy production. Previously, as Associate Director of Technical Operations at Landmark Bio, leadership was provided in building a multiproduct GMP facility and overseeing manufacturing operations for viral vectors and CAR-T products. A career spanning over fifteen years includes roles at Thermo Fisher Scientific, Paragon Bioservices, and Wockhardt, focusing on process development, technology transfer, and GMP manufacturing of various biopharmaceuticals. Virendra's educational background includes an MS in Chemical Engineering and an M Tech in Biotechnology, along with a Lean & Six Sigma Black Belt certification.